Yacca Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.82 Cr
as on 12-12-2024
- Satisfied Charges ₹ 8.16 Cr
as on 12-12-2024
- Revenue 127.62%
(FY 2021)
- Profit 121.06%
(FY 2021)
- Ebitda 4.43%
(FY 2021)
- Net Worth 18.67%
(FY 2021)
- Total Assets 14.50%
(FY 2021)
About Yacca Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹20.82 Cr. The company has closed loans amounting to ₹8.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anjali Bansal, Pankaj Bansal, Prateek Bansal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110UR2015PTC001698
- Company No.
001698
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Yacca Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aayush Bansal  | Director | 10-Aug-2018 | Current |
| Anjali Bansal | Director | 16-Sep-2015 | Current |
| Pankaj Bansal | Director | 16-Sep-2015 | Current |
| Prateek Bansal | Director | 10-Aug-2018 | Current |
Financial Performance of Yacca Lifesciences.
Yacca Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 127.62% increase. The company also saw a substantial improvement in profitability, with a 121.06% increase in profit. The company's net worth Soared by an impressive increase of 18.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yacca Lifesciences?
In 2021, Yacca Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yacca Pharmaceuticals Private LimitedActive 35 years 14 daysAnjali Bansal, Pankaj Bansal and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Aug 2023 | ₹2.25 M | Open |
Others Creation Date: 15 Mar 2018 | ₹20.59 Cr | Open |
Hdfc Bank Limited Creation Date: 22 Sep 2020 | ₹8.16 Cr | Satisfied |
How Many Employees Work at Yacca Lifesciences?
Yacca Lifesciences has a workforce of 56 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yacca Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yacca Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
